Cambrex - 28 Year Dividend History | CBM

Historical dividend payout and yield for Cambrex (CBM) since 1991. The current TTM dividend payout for Cambrex (CBM) as of June 18, 2019 is $0.00. The current dividend yield for Cambrex as of June 18, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.470B $0.532B
Cambrex Corporation is an innovative life sciences company with a refreshingly human approach. Driven by passion, their pharmaceutical products, expertise and technologies accelerate customers' small molecule therapeutics into markets across the world. The company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances. Cambrex has transformed from a fine chemical manufacturer to a business with a singular focus on small molecule therapeutics.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $110.770B 12.52
Gilead Sciences (GILD) United States $86.948B 10.56
Bio-Techne Corp (TECH) United States $7.858B 53.62